Clinical Trial Update: Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Endoxifen for Bipolar I Disorder has completed, sponsored by Jina Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Endoxifen (Endoxifen)

Snippet

Sponsor: Jina Pharmaceuticals Inc. | Conditions: Bipolar I Disorder | Phase 3 | Status: COMPLETED